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Purpose: To evaluate the anti-Streptococcus pyogenes activity of selected medicinal plants used in 
Thai traditional medicine. 
Methods: Sixty-nine extracts of 51 selected Thai medicinal plant species were tested for anti-S. 
pyogenes activity by paper disc agar diffusion and broth microdilution methods.  
Results: Ten plants including Boesenbergia pandurata (Roxb.) Schltr., Cinnamomum bejolghota 
(Buch.-Ham.) Sweet, Cinnamomum porrectum (Roxb) Kosterm, Eleutherine americana Merr., 
Gymnopetalum cochinchinensis (Lour.) Kurz, Piper betle L., Quercus infectoria G. Olivier, Quisqualis 
indica L, Rhodomyrtus tomentosa (Aiton) Hassk., and Walsura robusta Roxb. demonstrated good 
antibacterial activity against S. pyogenes NPRC 101. These plants were selected and further evaluated 
for their anti-S. pyogenes activity against 11 isolates of S. pyogenes from patients with upper respiratory 
tract infections. Three plants including Boesenbergia pandurata, Eleutherine americana, and 
Rhodomyrtus tomentosa exhibited good antibacterial activity against all S. pyogenes isolates and 
produced similar activities against different tested isolates. Boesenbergia pandurata and Rhodomyrtus 
tomentosa demonstrated antibacterial activity with the same minimal inhibitory concentration (MIC) and 
minimal bactericidal concentration (MBC) range of 3.91 - 31.25 µg/ml whereas Eleutherine americana 
displayed MIC and MBC values of 250 and 250-500 µg/ml against all S. pyogenes isolates. 
Conclusion: Boesenbergia pandurata, Eleutherine americana, and Rhodomyrtus tomentosa have great 
antibacterial potentials against S. pyogenes. 
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Upper respiratory tract infections (URTIs) are the 
most common human infection, mostly caused 
by viruses and bacteria. Streptococcus pyogenes 
is a major upper respiratory tract bacterial 
pathogen that causes a wide variety of diseases. 
It is the most common cause of bacterial 
pharyngitis and is linked to many serious 
complications [1]. Viral infections in upper 
respiratory tract are usually not an appropriate 
indication for the use of antibiotics. Bacteria that 
cause URTIs should be taken and cultured to 
determine the particular type of bacteria and 
antibiotics treatment are performed if necessary 
[2]. However, unnecessary and irrational self-
medication with antibiotics seems to be common 
for URTIs [3,4]  and these result in resistance to 
many bacteria including S. pyogenes [5,6]. 
Antibiotic misuse for URTIs is a serious problem 
that not only results in selection of resistant 
strains of bacteria but also waste of resources. 
Correlation of antibiotic resistance in S. 
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pyogenes with antibiotic consumption has been 
recorded. Increase in antibiotic use has resulted 
in increased prevalence of antibiotic-resistant S. 
pyogenes [7,8]. Hence, the search for alternative 
treatment dealing with URTIs caused by S. 
pyogenes is necessary. Medicinal plants are a 
great source of alternative treatment for many 
infections. The use of medicinal plants may 
substitute antibiotic consumption for URTIs or 
decrease antibiotic-resistant bacteria. 
 
In traditional Thai medicine, many medicinal 
plants have been in use since ancient times. 
Herbal medicines are relatively safer than 
synthetic drugs and offer profound therapeutic 
benefits [9]. A number of Thai medicinal plants 
have been studied for their antibacterial 
activities. There are several reports on 
antibacterial activity of plants that inhibit various 
bacterial pathogens, but only limited number of 
studies on S. pyogenes, an important bacterial 
human pathogen, have been published. 
Therefore, this study was aimed to evaluate the 
antibacterial activity of selected medicinal plants 
commonly used in traditional Thai medicine for 
bacterial infections against S. pyogenes isolated 




Preparation of plant extract 
 
Fifty-one medicinal plant species used in 
traditional Thai medicine for bacterial infections 
were selected. The plant materials were 
collected from various areas of the southern 
region of Thailand from 2006 - 2007. Quercus 
infectoria nut galls were purchased from an herb 
shop in Songkhla, Thailand. Botanical 
identification was performed by Dr. Oratai 
Neamsuvan, an ethnobotanist at the Faculty of 
Traditional Thai Medicine, Prince of Songkla 
University, where their voucher specimens are 
deposited. All plant materials were cut into small 
pieces and dried at 60 C overnight. The dried 
plant materials were crushed in a mechanical 
mortar and soaked in extracted solvent for 7 
days (3 times). The solvent was then filtered and 
dried using a rotary evaporator. All extracts were 
stored at -4 C, and dissolved in dimethyl 
sulfoxide (DMSO, Merck, Germany) before use. 
The aliquots were checked for sterility by 
streaking with a sterile loop on brain heart 
infusion (BHI) agar and incubating at 37 °C 
overnight. 
 
Bacterial strain and culture conditions  
 
Eleven clinical isolates of S. pyogenes (NPRC 
101-111) from patients with tonsillitis or 
pharyngitis were obtained from Department of 
Microbiology and Natural Products Research 
Center, Faculty of Science, Prince of Songkla 
University. All isolates were susceptible to 
erythromycin and penicillin G. These isolates 
were stored in BHI broth supplement with 20 % 
glycerol at -70 °C. All the isolates were routinely 
cultured in BHI broth or blood agar (BA) plates 
and incubated with 5 % CO2 at 37 oC for 24 h. 
 
Screening for anti-S. pyogenes activity 
  
The preliminary screening of all plant extracts for 
their anti-S. pyogenes activity was carried out  by 
disc agar diffusion method [10]. The extracts 
were dissolved in DMSO (250 mg/ml) and then 
10 µl were applied to sterile filter paper discs 
(Whatman No. 1; 6 mm in diameter) so that each 
disc finally yielded 2.5 mg of the extract. Dry 
discs (dried at 37 °C overnight) were applied 
onto the surface of 5% blood Mueller Hinton agar 
(MHA) plates seeded with the culture of S. 
pyogenes. The plates were then incubated with 
5% CO2 at 37 °C for 20 h. Dimethyl sulphoxide, 
extraction solvents, and antibiotic discs including 
erythromycin (15 µg) and penicillin G (1 µg) were 
used as controls. The experiment was carried out 
in duplicate and the average diameter of 
inhibition zone was calculated. 
 
Determination of minimal inhibitory 
concentration (MIC) and minimal bactericidal 
concentration (MBC) 
 
A broth microdilution method according to 
Clinical and Laboratory Standards Institute 
Guidelines (CLSI) was used to determine the 
MIC and MBC of the plant extracts against S. 
pyogenes [10]. Erythromycin was used as 
reference antibiotic. MIC was recorded as the 
lowest concentration that produced a complete 
suppression of visible growth. MBC was taken as 
the concentration that gave significant MIC 
values using a sterile loop streaking on fresh 




Screening for anti-S. pyogenes activity 
 
The antibacterial activities of 51 medicinal plant 
species used in Thai traditional medicine for 
bacterial infections against S. pyogenes NPRC 
101 are presented in Table 1. Among the plants 
tested, nearly all extracts, except Murdannia 
loriformis, produced inhibition zones on S. 
pyogenes NPRC 101. The inhibition zones 
ranged from 7 - 26 mm. Ethanol extracts of Piper 
betle, Coriandrum sativum, Quercus infectoria, 
and Eleutherine americana demonstrated large 
Limsuwan & Voravuthikunchai 
Trop J Pharm Res, August  2013;12 (4): 
 
537 
zones with diameters of 26, 24, 23, and 23 mm, 
respectively. Thirty four extracts (26 plant 
species) from a total of 69 extracts (51 plant 
species) possessed MIC values ≤ 1000 µg/ml on 
S. pyogenes NPRC 101. Only 22 extracts (17 
plant species) exhibited bactericidal activity at 
MBC values ≤ 1000 µg/ml. Among the plant 
species tested, Rhodomyrtus tomentosa (flower, 
fruit, and leaf extracts) and Boesenbergia 
pandurata (rhizome extract) produced better 
activity against S. pyogenes NPRC 101, as 
indicated by lower MIC and MBC values. 
 
Table 1: Antibacterial activity of selected Thai medicinal plants against Streptococcus pyogenes NPRC 101 
 










Acacia catechu (L.f.) Willd.  Fabaceae NPRCP0001 core 5.60e 11 1000/1000 
Aegle marmelos (L.) Correa Rutaceae NPRCP0002 fruit 5.37e 15 1000/1000 
Alstonia scholaris (L.) R. Br.  Apocynaceae NPRCP0003 wood 1.30a 8 1000/1000 






Asclepias curassavica L. Asclepiadaceae NPRCP0005 wood 0.98e 14 1000/1000 
Boesenbergia pandurata (Roxb.) 
Schltr. 
Zingiberaceae NPRCP0006 rhizome 1.58c 7 7.81/7.81 
Cassia alata L.  Fabaceae NPRCP0007 leaf 4.20a 9 1000/1000 
Centella asiatica (L.) Urb.  Apiaceae NPRCP0008 leaf 6.00e 15 1000/1000 
Cinnamomum bejolghota (Buch.-Ham.) 
Sweet 








Cinnamomum porrectum (Roxb.) 
Kosterm. 








Cleome gynandra L. Capparaceae NPRCP0011 whole 
plant 
6.76e 11 1000/1000 






Curcuma zedoaria (Christm.) Roscoe  Zingiberaceae NPRCP0013 rhizome 9.60e 11 500/500 






Dracaena loureoiri Gangnep.  Agavaceae NPRCP0015 core 16.90e 15 1000/1000 






Eleutherine americana Merr. Iridaceae NPRCP0017 bulb 4.80e 23 250/500 
Euphorbia thymifolia L.  Euphorbiaceae NPRCP0018 whole 
plant 
1.30e 15 500/1000 
Gymnopetalum cochinchinensis (Lour.) 
Kurz 
Cucurbitaceae NPRCP0019 fruit 7.66e 15 250/500 
Holarrhena antidysenterica (L.) Wall. 
ex A. DC.  
Apocynaceae NPRCP0020 bark 2.10e 15 500/500 
Impatiens balsamina L.  Balsaminaceae NPRCP0021 leaf 5.20e 15 1000/1000 
Manilkara achras (Mill.) Fosberg Sapotaceae NPRCP0022 fruit 26.77e 9 1000/1000 
Millingtonia hortensis L. f. Bignoniaceae NPRCP0023 flower 25.41e 8 1000/1000 
Mimosa pudica L. Fabaceae NPRCP0024 whole 
plant 
4.91e 10 1000/1000 
Mitragyna speciosa (Korth.) Havil Rubiaceae NPRCP0025 leaf 5.96e 8 1000/1000 
Momordica charantia L.  Cucurbitaceae NPRCP0026 vine 3.00e 15 1000/1000 
Morinda citrifolia L. Rubiaceae NPRCP0027 fruit 7.36e 9 1000/1000 
Murdannia loriformis (Hassk.) R.S. 
Rao & Kammathy 
Commelinaceae NPRCP0028 whole 
plant 
7.67e -b NAc 
Oroxylum indicum (L.) Kurz Bignoniaceae NPRCP0029 bark 3.71e 10 1000/1000 
Peltophorum pterocarpum (DC.) 
Backer ex K. Heyne 









Phyllanthus amarus Schumach. & 
Thonn. 
Euphorbiaceae NPRCP0031 whole 
plant 
7.82e 10 1000/1000 
Piper betle L. Piperaceae NPRCP0032 leaf 9.19e 26 500/500 
Piper chaba Hunter Piperaceae NPRCP0033 fruit 8.96e 9 1000/1000 
Piper nigrum L. Piperaceae NPRCP0034 fruit 6.33e 10 1000/1000 
Piper sarmentosum Roxb. Piperaceae NPRCP0035 leaf 4.72e 20 1000/1000 
Pluchea indica (L.) Less.  Asteraceae NPRCP0036 leaf 17.80e 14 500/1000 
Psidium guajava L.  Myrtaceae NPRCP0037 leaf 2.80a 12 1000/1000 
Quercus infectoria G. Olivier Fagaceae NPRCP0038 nut gall 57.15e 23 500/1000 
Quisqualis indica L. Combretaceae NPRCP0039 flower 11.08e 17 250/500 
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Table 1 (contd.): Antibacterial activity of selected Thai medicinal plants against Streptococcus pyogenes NPRC 101  
 
































Tamarindus indica L.  Fabaceae NPRCP0043 leaf 4.80e 14 1000/1000 
Terminalia bellirica (Gaertn.) Roxb. Combretaceae NPRCP0044 fruit 14.88e 15 1000/1000 
Terminalia chebula Retz. Combretaceae NPRCP0045 fruit 17.20e 13 1000/1000 
Terminalia sp. Combretaceae NPRCP0046 fruit 23.90e 17 1000/1000 
Theobroma cacao L. Sterculiaceae NPRCP0047 pericarp 3.67e 9 1000/1000 






















Wrightia tomentosa (Roxb.) Roem. & 
Schult.  
Apocynaceae NPRCP0050 stem 3.90e 15 500/1000 








Erythromycin      0.125/0.125 
aConcentration of the extract = 2.5 mg/disc; bNo inhibition zone; cNot applicable.  
a: Aqueous; b: n-Butanol; c: Chloroform; d: Dichloromethane: e: Ethanol; et: Ethyl acetate; m: Methanol; h: Hexane 
 
Table 2: Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of 10 plant extracts 
against clinical Streptococcus pyogenes isolates (n = 11) 
 
Botanical species Part tested MIC range (µg/ml) MBC range (µg/ml) 
Boesenbergia pandurataa rhizome 3.91-31.25 7.81-62.50 












Eleutherine americanab bulb 250 250-500 
Gymnopetalum cochinchinensisb fruit 31.25->1000 31.25->1000 
Piper betleb leaf 500-1000 500-1000 
Quercus infectoriab nut gall 125->1000 125->1000 
Quisqualis indicab flower 250->1000 250->1000 
Rhodomyrtus tomentosab leaf 3.91-31.25 3.91-62.50 
Walsura robustac leaf, branch 62.50->1000 62.50->1000 
Erythromycin  <0.015-0.125 <0.015-0.125 
 
aChloroform extract; bEthanol extract; cEthyl acetate extract.  
 
Anti-S. pyogenes activity of plant extracts 
    
Ten effective plants, including Boesenbergia 
pandurata, Cinnamomum bejolghota, 
Cinnamomum porrectum, Eleutherine americana, 
Gymnopetalum cochinchinensis, Piper betle, 
Quercus infectoria, Quisqualis indica, 
Rhodomyrtus tomentosa, and Walsura robusta 
were selected based on their antibacterial activity 
against S. pyogenes NPRC 101 to further 
determine the variability of MICs and MBCs 
against 11 clinical isolates.  The MIC and MBC 
values of these 10 effective plants against 11 
clinical isolates of S. pyogenes are shown in 
Table 2.  Variations in the MIC and MBC values 
were found among the bacterial isolates when 
tested with the extracts of Cinnamomum 
bejolghota, Cinnamomum porrectum, 
Gymnopetalum cochinchinensis, Quercus 
infectoria, Quisqualis indica, and Walsura 
robusta.  These plants exhibited a wide range of 
MIC and MBC values, from 31.25 - >1000 and 
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31.25 - >1000 µg/ml, respectively.  In contrast, 
three plant species including Boesenbergia 
pandurata, Eleutherine americana, and 
Rhodomyrtus tomentosa showed similar 
antibacterial activity among different 11 clinical 
isolates. Boesenbergia pandurata and 
Rhodomyrtus tomentosa demonstrated very 
good antibacterial activity with MIC and MBC 
values ranged from 3.91 - 31.25, 3.91 - 31.25 
and 7.81 - 62.50, 3.91 - 62.50 µg/ml, 
respectively. Meanwhile the extract of 
Eleutherine americana demonstrated moderate 
activity against all isolates with the MIC and MBC 
values of 250 and 250 - 500 µg/ml, respectively. 
All isolates tested were sensitive to erythromycin 




A number of plant extracts can be screened for 
their anti-S. pyogenes properties quickly using 
paper disc assay. However, this assay is not 
classically quantitative and using the size of 
inhibition zone to indicate relative antibacterial 
activity is not sufficient. The zone of inhibition 
may be affected by many factors such as the 
evaporation, solubility, and diffusion rate of the 
active components through test medium. Zone of 
inhibition testing is particularly appropriate for 
determining the ability of water-soluble 
antimicrobial compounds to inhibit the growth of 
microorganisms. Therefore, the MIC/MBC values 
and zone of inhibition of some of the plant 
extracts in this study did not correlate. For 
example, Boesenbergia pandurata extract 
generated a very small zone of inhibition (7 mm) 
but possessed very good MIC and MBC values. 
 
In this study, we found that the extracts of 
Boesenbergia pandurata, Eleutherine americana, 
and Rhodomyrtus tomentosa not only 
demonstrated good antibacterial activity against 
S. pyogenes isolated from upper respiratory tract 
infections but also produced similar activities 
against different S. pyogenes clinical isolates.  
 
In Thai traditional medicine, the rhizomes of 
Boesenbergia pandurata are used to treat colic 
disorders, wound infections and inflammation 
[11]. The antibacterial activities of this plant have 
been reported [12]. Some antibacterial active 
components from this plant were isolated and 
studied for their activities. Pinostrobin isolated 
from this plant demonstrated anti-Helicobacter 
pylori activity [13]. Panduratin A from this plant 
displayed significant antibacterial activity against 
a number of staphylococci and enterococci 
clinical isolates. Notably, the antibacterial activity 
of panduratin A was more potent than many 
reference antibiotics [14,15]. Isopanduratin A 
from this plant demonstrated antibacterial activity 
against many streptococci including 
Streptococcus mutans, Streptococcus sobrinus, 
Streptococcus sanguinis, and Streptococcus 
salivarius [16,17].   
 
Eleutherine americana is a herbal plant whose 
red bulb was used as a folk medicine and 
flavouring agent. In the screening test we found 
that the bulb extract of this plant demonstrated 
moderately strong activity against S. pyogenes 
when compared with other plant extracts. 
However, when we increased the number of 
bacterial isolates it could produce similar 
antibacterial activity against difference S. 
pyogenes isolates. The antibacterial activities of 
this plant have been previously reported against 
gram-negative [18] and gram-positive bacteria 
[19]. Several compounds from this plant such as 
eleuthinone A, eleuthraquinone A and B, and 
eleucanarol have been isolated and studied for 
their antibacterial activities against 
Staphylococcus aureus [20].  
 
Rhodomyrtus tomentosa is a Thai medicinal 
plant used to treat skin, oral, gastrointestinal, and 
urinary tract infections. In this study, we found 
that the extracts of flower, fruit, and leaf 
demonstrated good antibacterial activity against 
S. pyogenes. The leaf extract of this plant has 
been reported for its antibacterial activity against 
many bacterial pathogens [19]. An isolated 
compound, named rhodomyrtone, from the leaf 
of this plant exhibited strong antibacterial activity 
against many pathogenic Gram-positive bacteria 
[21-23] including S. pyogenes [24]. Moreover, 
rhodomyrtone possessed noteworthy activity 
against methicillin-resistant S. aureus, displaying 





Our study demonstrated that the plants species 
including Boesenbergia pandurata, Eleutherine 
americana, and Rhodomyrtus tomentosa have 
great potentials as antibacterial agents against S. 
pyogenes. Thus, these plants may yield 
biologically active compounds that might be 
valuable in the treatment of the diseases caused 
by S. pyogenes. Their active components, 
however, need to be isolated, and their toxicity 
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